These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 27098014)
1. Enhancing clinical evidence by proactively building quality into clinical trials. Meeker-O'Connell A; Glessner C; Behm M; Mulinde J; Roach N; Sweeney F; Tenaerts P; Landray MJ Clin Trials; 2016 Aug; 13(4):439-44. PubMed ID: 27098014 [TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology policy statement: oversight of clinical research. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281 [TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
4. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative. Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947 [TBL] [Abstract][Full Text] [Related]
5. Improving the quality conduct and efficiency of clinical trials with training: Recommendations for preparedness and qualification of investigators and delegates. Bechtel J; Chuck T; Forrest A; Hildebrand C; Panhuis J; Pattee SR; Comic-Savic S; Swezey T Contemp Clin Trials; 2020 Feb; 89():105918. PubMed ID: 31881391 [TBL] [Abstract][Full Text] [Related]
6. Gatekeepers for pragmatic clinical trials. Whicher DM; Miller JE; Dunham KM; Joffe S Clin Trials; 2015 Oct; 12(5):442-8. PubMed ID: 26374683 [TBL] [Abstract][Full Text] [Related]
7. Clinical trials recruitment planning: A proposed framework from the Clinical Trials Transformation Initiative. Huang GD; Bull J; Johnston McKee K; Mahon E; Harper B; Roberts JN; Contemp Clin Trials; 2018 Mar; 66():74-79. PubMed ID: 29330082 [TBL] [Abstract][Full Text] [Related]
8. A decade of the Clinical Trials Transformation Initiative: What have we accomplished? What have we learned? Tenaerts P; Madre L; Landray M Clin Trials; 2018 Feb; 15(1_suppl):5-12. PubMed ID: 29452517 [TBL] [Abstract][Full Text] [Related]
12. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review. Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062 [TBL] [Abstract][Full Text] [Related]
13. Ensuring participant safety and trial integrity with clinical trials oversight. Godfrey C; Payton M; Tasker S; Proestel S; Schouten JT J Acquir Immune Defic Syndr; 2014 Jan; 65 Suppl 1(0 1):S40-3. PubMed ID: 24321985 [TBL] [Abstract][Full Text] [Related]
14. Critical Care Network in the State of Qatar. Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205 [TBL] [Abstract][Full Text] [Related]
15. Harmonization and streamlining of research oversight for pragmatic clinical trials. O'Rourke PP; Carrithers J; Patrick-Lake B; Rice TW; Corsmo J; Hart R; Drezner MK; Lantos JD Clin Trials; 2015 Oct; 12(5):449-56. PubMed ID: 26374678 [TBL] [Abstract][Full Text] [Related]
16. Exploring the ethical and regulatory issues in pragmatic clinical trials. Califf RM; Sugarman J Clin Trials; 2015 Oct; 12(5):436-41. PubMed ID: 26374676 [TBL] [Abstract][Full Text] [Related]
17. The Clinical Trials Transformation Initiative: Methodology supporting the mission. Corneli A; Hallinan Z; Hamre G; Perry B; Goldsack JC; Calvert SB; Forrest A Clin Trials; 2018 Feb; 15(1_suppl):13-18. PubMed ID: 29452520 [TBL] [Abstract][Full Text] [Related]
18. Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team. Knirsch C; Alemayehu D; Botgros R; Comic-Savic S; Friedland D; Holland TL; Merchant K; Noel GJ; Pelfrene E; Reith C; Santiago J; Tiernan R; Tenearts P; Goldsack JC; Fowler VG Clin Infect Dis; 2016 Aug; 63 Suppl 2():S29-36. PubMed ID: 27481950 [TBL] [Abstract][Full Text] [Related]
19. A third trial oversight committee: Functions, benefits and issues. Lane JA; Gamble C; Cragg WJ; Tembo D; Sydes MR Clin Trials; 2020 Feb; 17(1):106-112. PubMed ID: 31665920 [TBL] [Abstract][Full Text] [Related]
20. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review. Allen D; Gillen E; Rixson L JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]